Dr. Rosas’ main area of research interest are the prevention, diagnosis and treatment of pulmonary fibrosis, a condition that affects genetically susceptible individuals and the elderly. Clinically his program has focused on defining populations at risk of developing pulmonary fibrosis, identifying disease biomarkers and the design and execution of clinical trials testing novel treatments for pulmonary fibrosis. In the laboratory, his research team employs cutting edge genomic technologies and translational models to determine how select molecular derangements contribute to the development and progression of parenchymal lung disease. The long-term goal of this translational research program is to better understand mechanisms that contribute to disease progression and to infor the development of novel diagnostic and therapeutic strategies for patients affected with fibrotic lung disease.
